
In Vitro Fertilization Market Size Was Valued at USD 759.40 Million in 2023 and is Projected to Reach USD 1718.69 Million by 2032, Growing at a CAGR of 9.5% From 2024-2032.
In Vitro Fertilization is a process of Fertilization in which eggs are removed from a woman’s ovary and combined with sperm outside the body in vitro conditions to form embryos. The embryos are grown in the laboratory for several days and then either placed in a woman’s uterus or cryopreserved for future use also called IVF.The IVF technique can be more beneficial in Overcoming infertility, for couples who have difficulty conceiving naturally due to factors like blocked fallopian tubes, low sperm count, or any other ovulation disorders.
It is also applicable in Genetic screening to screen embryos for genetic disorders, this helps in the selection of healthy embryos for transfer and reduces the risk of passing on genetic conditions It also allows individuals to preserve their fertility by cryopreservation technique for freezing embryos, eggs, or sperm for future use, which is particularly helpful for individuals who are undergoing treatments like chemotherapy which may affect their fertility. It also enables same-gender couples and single individuals to have biological children. It is used in gestational surrogacy, which allows individuals to carry a pregnancy and have a biological child for those who have no child. It has also contributed to advancements in reproductive research, like studying early embryonic development and improving assisted reproductive technologies.
“TFP Fertility, Vitrolife AB, Irvine Scientific, Thermo Fisher Scientific Inc., Merck KGaA (EMD Serono), Ferring Pharmaceuticals, Esco Micro Pte Ltd, Boston IVF, IVFtech ApS, Rocket Medical plc, IVI Fertility, THE COOPER COMPANIES, INC, COOK GROUP, VITROLIFE, Servy Massey Fertility Institute, Houston Fertility Center, Conceptions Reproductive Associates of Colorado, New Hope Fertility Center, Sher Institute for Reproductive Medicine (Sirm), Cardone Reproductive Medicine and Infertility, Fertility Center of San Antoni, Reproductive Medicine Associate, Fertility And Gynecology Center Monterey Bay Ivf, Nikon Corporation, Cooper Companies Inc. and Other Active Players.”
In Vitro Fertilization Market Segmented on the basis of Product Type, Type, Cycle, End-User, Segment5, And Segment6.
In Vitro Fertilization Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 759.40 Mn. |
Forecast Period 2024-32 CAGR: |
9.5 % |
Market Size in 2032: |
USD 1718.69 Mn. |
Segments Covered: |
By Product Type |
|
|
By Type |
|
||
By Cycle |
|
||
By End-User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: In Vitro Fertilization Market by By Product Type
4.1 In Vitro Fertilization Market Snapshot and Growth Engine
4.2 In Vitro Fertilization Market Overview
4.3 Imaging Systems
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted
The forecast period in the In Vitro Fertilization Market research report is 2024-2032.
TFP Fertility, Vitrolife AB, Irvine Scientific, Thermo Fisher Scientific Inc., Merck KGaA (EMD Serono), Ferring Pharmaceuticals, Esco Micro Pte Ltd, Boston IVF, IVFtech ApS, Rocket Medical plc, IVI Fertility, THE COOPER COMPANIES, INC, COOK GROUP, VITROLIFE, Servy Massey Fertility Institute, Houston Fertility Center, Conceptions Reproductive Associates of Colorado, New Hope Fertility Center, Sher Institute for Reproductive Medicine (Sirm), Cardone Reproductive Medicine and Infertility, Fertility Center of San Antoni, Reproductive Medicine Associate, Fertility And Gynecology Center Monterey Bay Ivf, Nikon Corporation, Cooper Companies Inc. and Other Active Players.
The In Vitro Fertilization Market is segmented into Product Type, Type, Cycle, End-User, Segment5, Segment6, and region. By Product Type, the market is categorized into Imaging Systems, Incubators, Cryosystems, IVF Cabinet, Ovum Aspiration Pump, Sperm Separation Devices, Micromanipulators, Other {Laser systems, Gas Analyzers, Anti-Vibration Tables}. By Type, the market is categorized into Conventional IVF, IVF with ICSI, IVF with Donor Eggs, and Others {Traditional IVF}. By Cycle, the market is categorized into Fresh Non-donor IVF Cycles, Frozen Non-donor IVF Cycles, Frozen Donor IVF Cycles, and Fresh Donor IVF Cycles. By End-User, the market is categorized into Fertility clinics, Hospitals & Surgical Centers, Cryobanks, and Research Institutes. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
In Vitro Fertilization is a process of Fertilization in which eggs are removed from a woman’s ovary and combined with sperm outside the body in vitro conditions to form embryos.
In Vitro Fertilization Market Size Was Valued at USD 759.40 Million in 2023 and is Projected to Reach USD 1718.69 Million by 2032, Growing at a CAGR of 9.5% From 2024-2032.